UOC
STRO icon

UBS O'Connor’s Sutro Biopharma STRO Stock Holding History

UBS O'Connor’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,828
Closed -$18.4K – 449
2025
Q1 		$18.4K Sell
2,828
-27,234
-91% -$429K ﹤0.01% 302
2024
Q4 		$553K Sell
30,062
-3,760
-11% -$115K 0.01% 274
2024
Q3 		$1.17M Buy
33,822
+6,316
+23% +$248K 0.03% 259
2024
Q2 		$806K Buy
27,506
+2,000
+8% +$79.1K 0.02% 328
2024
Q1 		$1.44M Sell
25,506
-12,328
-33% -$545K 0.04% 237
2023
Q4 		$1.62M Buy
37,834
+4,834
+15% +$153K 0.05% 207
2023
Q3 		$1.15M Buy
+33,000
New +$1.44M 0.02% 317

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return